David Fivenson, Md, Dermatology, Pllc

Ann Arbor, Michigan 48103-9746

1 studies enrolling now · 9 studies all time

What they study most

Angioedema, Chronic Cutaneous Lupus Erythematosus, Chronic Idiopathic Urticaria, Chronic Spontaneous Urticaria, Diabetes Complications, Foot Ulcer, Diabetic, Hives, Lichen Planus, Onychomycosis, Plaque Psoriasis, Pruritis, Psoriasis

Studies at this site

• A Long-Term Extension Study to Learn More About the Safety of Litifilimab (BIIB059) Injections and Whether They Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus — Enrolling by invitation
• A 2-Part Study to Learn Whether Litifilimab (BIIB059) Injections Can Improve Symptoms of Adult Participants Who Have Active Cutaneous Lupus Erythematosus — Running, not enrolling
• Study Evaluating the Efficacy and Safety of Povorcitinib in Adults With Chronic Spontaneous Urticaria — Completed
• A Study About How Well TAK-279 Works and Its Safety in Participants With Moderate-to-severe Plaque Psoriasis During 60 Weeks of Treatment With a Withdrawal and Retreatment Period — Completed
• A Vehicle-controlled Study of Topical MOB015B in the Treatment of Distal Subungual Onychomycosis (DSO) — Status unconfirmed
• Use of Etanercept in the Treatment of Moderate to Severe Lichen Planus — Stopped early
• A Study to Evaluate Psoriasis Outcomes and Safety Events in Patients With Chronic Moderate to Severe Plaque Psoriasis (RESPONSE) — Completed
• The Safety and Efficacy of Topical IDP-108 Versus Vehicle in Patients With Onychomycosis — Completed
• Safety and Efficacy Study of MRE0094 to Treat Chronic, Neuropathic, Diabetic Foot Ulcers — Completed